Integrated Quantitative Investments LLC
Position in COLL — Collegium Pharmaceutical, Inc
CIK 2046834
BELLEVUE, WA
Position in COLL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,738,939
+$713,340 QoQ
Shares Held
48,037
+54.9% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#82
of 279 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Integrated Quantitative Investments LLC holds $10,389,461 across 8 Drug Manufacturers - Specialty & Generic names. COLL ranks #3 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
61,555 | $2,525,601 | |
| 2 | LQDA |
Liquidia Corp
|
31,620 | $2,521,062 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
This page
|
48,037 | $1,738,939 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
8,505 | $1,433,432 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
37,396 | $1,174,234 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
93,689 | $394,430 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
38,501 | $322,638 | |
| 8 | ANIK |
Anika Therapeutics, Inc.
|
19,079 | $279,125 |
All Filings in COLL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,738,939 | 48,037 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,025,599 | 31,013 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,641,612 | 35,456 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $298,639 | 8,535 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $976,549 | 33,025 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $986,632 | 33,053 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $948,372 | 33,102 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||